In addition, Austrian Breast and Colorectal Cancer Study Group Trial 06 enrolled early-stage breast cancer patients with an ER/PR hormonal-positive status for evaluation of p27Kip1 expression and observed its impact on the clinicopathological features of women receiving adjuvant tamoxifen for 5 years. Here, CDKN1B is linked to breast cancer.